ArticleJournal of experimental & clinical cancer research : CR2023

Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8

Feng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.